Activation of T-cell hybridomas, preactivated normal T cells, and peripheral blood lymphocytes (PBL) from human immunodeficiency virus (HIV)-infected individuals results in apoptosis. In the first two cases, apoptosis is caused by the upregulation of Fas ligand (FasL) and its subsequent interaction with Fas; the mechanism for the spontaneous and activation-induced death of lymph node cells and PBL from HIV+ blood is not known. A number of protease inhibitors have been shown to prevent T-cell apoptosis under all of these circumstances, but the mechanism of action has not been determined. Here we show that the cysteine protease inhibitor E64d prevents activation-induced T hybridoma cell death by inhibiting the upregulation of FasL. Quantitative polymerase chain reaction (PCR) demonstrated that mRNA for FasL is expressed at low levels in fresh PBL from HIV-infected blood, but increases in cultured PBL from both uninfected and HIV-infected donors. The ex vivo apoptosis of PBL from HIV+ donors was prevented by adding the soluble extracellular domain of Fas, demonstrating a requisite role for Fas/FasL interactions in this form of cell death. Furthermore, while having no effect on the death of PBL from HIV-infected blood stimulated directly via Fas, E64d inhibited FasL upregulation. Thus, aberrant apoptosis of cultured PBL from HIV-infected individuals is mediated by FasL and Fas, and E64d blocks this apoptosis by inhibiting the upregulation of FasL. These results are consistent with the hypothesis that the abnormal expression of Fas and the inducible expression of FasL contributes to the immunodeficiency of patients with acquired immune deficiency syndrome and suggest that modulation of FasL expression could be an effective target for therapeutic intervention.

ACTIVATION OF T CELLS via the T-cell receptor (TCR) results in apoptosis under certain circumstances, a response that plays an important role in the development and function of the immune system.1 For example, potentially autoreactive thymocytes are eliminated by activation-induced apoptosis (negative selection), a major mechanism for the establishment of self-tolerance.2 Activated peripheral T cells are also susceptible to activation-induced cell death, which serves to dampen ongoing immune responses.3 It has recently become clear that activation-induced death of cells such as murine T-cell hybridomas and preactivated human peripheral blood lymphocytes (PBL) is mediated by Fas, a transmembrane molecule belonging to the tumor necrosis factor receptor (TNFR) superfamily.4-8 In these cases, activation of T cells results in upregulation of Fas and FasL, and the interaction between this receptor/ligand pair causes cell death. Impairment of this activation-regulated death in mice, either by mutations in Fas (lpr mice) or FasL (gld mice), results in lymphoproliferation (the accumulation of CD4 CD8 TCR+ T cells) and autoimmune disease.9-11 Recently, mutations in Fas and impaired Fas-mediated apoptosis have been identified in patients with a lymphoproliferative syndrome.12 13 Thus, Fas-mediated apoptosis is a critical means of maintaining peripheral T-cell homeostasis and regulating the immune response.

Infection with human immunodeficiency virus (HIV) is associated with early CD4+ T-cell dysfunction and a later decrease in absolute CD4+ T-cell number.14 Many mechanisms have been proposed for the loss of CD4+ T cells, including a direct cytopathic effect of HIV on CD4+ T cells or their precursors, HIV gp120-mediated cross-linking of CD4 and subsequent cell death as a consequence of T-cell receptor (TCR) engagement, production of soluble cytotoxic molecules by infected cells, autoimmune phenomena, and superantigen-induced activation/death.15 An intriguing observation in this regard is that T cells from HIV+ individuals spontaneously undergo apoptosis when cultured in vitro and that, in some circumstances, this cell death can be increased by activation with mitogens or superantigens.16-18 This phenomenon was not observed in HIV-seronegative individuals suffering from acute or chronic infectious diseases.16 Furthermore, ex vivo cell death has also been observed in simian immunodeficiency virus (SIV)-infected rhesus macaques, which develop an acquired immune deficiency syndrome (AIDS)-like syndrome, but not HIV-infected chimpanzees that do not develop the disease.19,20 Inappropriate cell death is not simply an in vitro phenomenon: spontaneous apoptosis of HIV-negative bystander cells in lymph nodes from HIV-infected individuals has been found to be threefold to fourfold higher than in uninfected controls and correlates with the degree of activation of the cells.21,22 These findings have led to the speculation that activation-induced T-cell death, unrelated to direct viral cytolysis, accounts for at least some of the loss of CD4+ T cells in AIDS.23 

Cysteine and serine protease inhibitors have been shown to prevent activation-induced T-cell apoptosis and the ex vivo death of PBL from HIV-infected individuals.24,25 Here we investigate the mechanism by which one of these cysteine protease inhibitors, E64d, mediates its effects. Our results demonstrate that E64d prevents activation-induced death of T hybridoma cells by inhibiting upregulation of FasL. Given that lymphocytes from HIV-infected individuals constitutively express abnormally high levels of Fas,26 27 the possible role of Fas and FasL in the death of PBL from HIV-infected individuals was also investigated. The data indicate that upregulated expression of FasL during culture and increased cellular sensitivity to Fas-mediated killing are responsible for ex vivo death of PBL from HIV-infected individuals, and that the inhibitory effect of E64d is due to inhibition of FasL upregulation.

Reagents.Antihuman Fas antibody CH-11 was purchased from Kamiya Biomedical Co (Thousand Oaks, CA). Fas:Fc and TNFR:Fc are recombinant chimeric molecules made of the extracellular portions of human Fas or human 55-kD TNF receptor fused to the Fc portion of human IgG1, respectively.8 28 E64d, a cysteine protease inhibitor, was obtained from Sigma Chemical Co (St Louis, MO). Taq polymerase was purchased from Boehringer Mannheim (Indianapolis, IN).

Cells.2B4.11 is a murine T-cell hybridoma specific for the antigen pigeon cytochrome c.29 PC60-d11S (d11S), a T-cell hybridoma that expresses FasL following activation, mouse leukemia cell L1210, and L1210-Fas (L1210 cells transfected with fas cDNA) were kindly provided by Dr P. Golstein.30 Heparinized venous peripheral blood was obtained from HIV-infected individuals who were admitted to National Cancer Institute (NCI) clinic. All patients had absolute CD4+ T-cell counts of 200 to 500 cells/μL, and informed consent was obtained. Blood samples from HIV-negative individuals were obtained from NIH blood bank. PBL were isolated using Lymphocyte Separation Medium (Organon Teknika Corp, Durham, NC). Cells were cultured in complete medium (RPMI 1640 plus 10% fetal calf serum, 4 mmol/L glutamine, 100 μg/mL gentamicin, 100 U/mL penicillin, and 5 μmol/L 2-mercaptoethanol).

PCR primers and generation of mutated competitive cDNA. Amplification of a primer pair for FasL (primer 1: 5′ GCC TCT GGA ATG GGA AGA CAC C 3′; primer 2: 5′ CAT CTG CCC AGT AGT GCA GTA G 3′ ) yielded a 241-bp DNA fragment. To generate an internal deletion mutant of this polymerase chain reaction (PCR) product, an oligonucleotide (primer 3: 5′ TAC TTC CGG GGT CAA AAG GTC TAC ATG AGG 3′ ) was made, which includes the 15 nucleotides at the 5′ and 3′ ends of the center 57-bp portion of the cDNA (without the middle 27 bp). Two amplifications were then performed using the 241-bp cDNA as template and either primer 3 and 2, or primer 1 and an antisense oligonucleotide of primer 3, as primers. The two PCR products were annealed and reamplified using primers 1 and 2. The resulting 214-bp cDNA was used as competitor for quantitation of FasL mRNA. The specificity of each PCR-amplified product was confirmed by restriction enzymes digestion. The oligonucleotide primers and the generation of the competitive mutant for actin were generated as described.31 

Quantitative competitive PCR. PBL were lysed with TE buffer containing 0.5% Triton-X 100, 4 U/mL of RNase inhibitor (Boehringer Mannheim), and 1 μmol/L dithiothreitol (DTT). After centrifugation at 14,000 rpm in Eppendorf tubes for 5 minutes, the supernatants were directly used for reverse transcription with an Invitrogen cDNA cycle kit (San Diego, CA). PCR amplification was then performed using primer 1 and 2 in the presence of increasing amounts of mutated cDNA (competitor). The reaction products were separated on a 4% agarose gel, stained with ethidium bromide, and visualized under ultraviolet (UV) light. Photographs were made with Polaroid Positive/Negative film (Polaroid, Cambridge, MA), and the negative scanned with a laser densitometer (PDI Imageware System, Huntington Station, NY). The ratios of the upper and lower bands were plotted as a function of the amount of mutated cDNA, and the amount of FasL cDNA was calculated from the linear regression line.

DNA fragmentation assay. DNA fragmentation was quantitated by adherence to fiberglass filters as described.32 Briefly, 2B4.11 cells or L1210 cells were labeled with [3H]thymidine (5 μCi/mL; 1 Ci = 37 GBq) for 3 hours in tissue culture. After thorough washing, 5 × 104 2B4 cells were distributed in triplicate into 96-well microtiter plates that had been coated with purified 2C11 at 1 μg/well as described33 or treated with complete medium. In some experiments, the labeled 2B4.11 cells were cocultured with different amounts of d11S cells, which had been activated with PMA (20 ng/mL) and ionomycin (3 μg/mL) for 3 hours and washed thoroughly. Following 16 hours of culture at 37°C in the presence or absence of E64d, the cells were hypotonically lysed and harvested onto fiberglass filters (PHD Cell Harvester; Cambridge Technology, Cambridge, MA). While intact chromatin DNA adheres to the filters, fragmented DNA passes through. The results are expressed as specific DNA fragmentation: [(M-E)/M] × 100%, where M is the retained label in cells cultured in medium and E is retained labeled in cells cultured under experimental conditions. To measure DNA fragmentation of L1210 and L1201-Fas cells, labeled cells were cocultured with activated or nonactivated 2B4.11 cells and harvested 6 hours later.

Northern blot analysis.Total RNA was made from 2B4.11 cells using acidic guanidine thiocyanate.34 The FasL probe was generated by PCR as described.8 The Pst fragment of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was kindly provided by Dr L. King (University of Pennsylvania School of Medicine, Philadelphia, PA). A total of 20 μg of RNA was loaded to each well of a 1% agarose gel and electrophoresed. After transfer to nylon membranes, hybridization with 32P-labeled FasL probe was performed in QuikHyb solution according to the procedures recommended by the manufacturer (Stratagene, San Diego, CA). The membrane was then stripped and reblotted for GAPDH.

Cell viability.Cell viability was assessed in duplicate by trypan blue exclusion and light microscopy. We have previously shown that this assay for cell viability correlates well with measurement of DNA fragmentation in PBL from HIV+ individuals.35 

E64d prevents activation-induced apoptosis of T-cell hybridomas by inhibiting FasL upregulation.The cysteine protease inhibitor E64d prevents activation-induced apoptosis of T-cell hybridomas and PBL from patients with AIDS.24,25 Since activation-induced T hybridoma death is mediated by the interaction of Fas and FasL,6-8 cysteine protease inhibition might block signal transduction via Fas and/or alters the expression FasL. It has previously been reported that E64d has no effect on killing of T-cell blasts caused by ligation of Fas,36 a finding that we confirmed with the 2B4.11 T-cell hybridoma (data not shown), suggesting that E64d interfered with apoptosis by inhibiting FasL expression. The effect of the cysteine protease inhibitor on FasL expression was assessed in two ways. As previously reported,8 FasL transcripts were undetectable in unstimulated 2B4.11 cells, but were easily seen 4 hours after stimulation with anti-CD3 (Fig 1). Although E64d had no effect on mRNA levels of the housekeeping gene GAPDH, it completely inhibited the induction FasL mRNA. To determine the biological relevance of FasL mRNA inhibition, the level of functional FasL protein expressed on the surface activated 2B4.11 cells was assessed. L1210 is a mouse leukemia cell line that expresses a low level of Fas on its surface and is relatively insensitive to FasL-induced killing.8,30 In contrast, L1210 cells transfected with fas rapidly undergo apoptosis when cultured with FasL+ cells, such as d11S or activated 2B4.11 cells.8 Unactivated 2B4.11 cells did not kill L1210 or L1210-Fas cells (data not shown), whereas activated 2B4.11 caused extensive death of the Fas+ but not the Fas target (Fig 2). To determine the effect of E64d on activation-induced FasL expression, 2B4.11 cells were activated with the indicated amounts of anti-CD3 antibody in the absence or presence of 100 μmol/L E64d for 2 hours, and [3H]thymidine labeled L1210 or L1210-Fas cells were then added into the culture and incubated for another 6 hours. As shown in Fig 2, L1210-Fas, but not L1210, cells were killed by activated 2B4.11. The killing was markedly inhibited when the T cells were activated in the presence of E64d. Furthermore, the inhibitory action of E64d was not due to inhibition of a Fas/FasL interaction or Fas-mediated killing because when the E64d was added together with L1210-Fas cells to activated 2B4.11 cells, the target cells still underwent apoptosis. Since E64d does not affect T-cell activation per se, as judged by interleukin-2 (IL-2) production24 (and our unpublished observation, June 1995), these data indicate that E64d specifically blocks activation-induced upregulation of FasL mRNA, which accounts for its ability to prevent activation-induced apoptosis.

Fig. 1.

E64d blocks the upregulation of Fas ligand mRNA induced by anti-CD3 antibody. 2B4.11 cells (106 cells/mL) were stimulated in 60-mm tissue culture dishes coated with 2C11 (20 μg/dish) for 4 hours in the presence or absence of 100 μmol/L E64d. Total RNA was extracted from the cells and Northern blot analysis performed.

Fig. 1.

E64d blocks the upregulation of Fas ligand mRNA induced by anti-CD3 antibody. 2B4.11 cells (106 cells/mL) were stimulated in 60-mm tissue culture dishes coated with 2C11 (20 μg/dish) for 4 hours in the presence or absence of 100 μmol/L E64d. Total RNA was extracted from the cells and Northern blot analysis performed.

Close modal
Fig. 2.

E64d blocks anti-CD3–induced upregulation of Fas ligand protein. 2B4.11 cells were activated with the indicated concentrations of plastic-coated 2C11 in the presence or absence of 100 μmol/L E64d for 2 hours. [3H]thymidine-labeled L1210 cells or L1210-Fas cells were then added to the cultures. The parentheses in the legend indicate the time of addition of E64d: (2B4.11 + E64d), E64d added at time 0; (E64d + L1210-Fas), E64d added with the L1210-Fas cells, 2 hours after initiation of the culture. After another 6 hours of incubation, the cells were harvested and the percentage of DNA fragmentation determined. Similar results were obtained in three independent experiments.

Fig. 2.

E64d blocks anti-CD3–induced upregulation of Fas ligand protein. 2B4.11 cells were activated with the indicated concentrations of plastic-coated 2C11 in the presence or absence of 100 μmol/L E64d for 2 hours. [3H]thymidine-labeled L1210 cells or L1210-Fas cells were then added to the cultures. The parentheses in the legend indicate the time of addition of E64d: (2B4.11 + E64d), E64d added at time 0; (E64d + L1210-Fas), E64d added with the L1210-Fas cells, 2 hours after initiation of the culture. After another 6 hours of incubation, the cells were harvested and the percentage of DNA fragmentation determined. Similar results were obtained in three independent experiments.

Close modal

Soluble Fas inhibits apoptosis of cultured HIV+ PBL.PBL from HIV-infected individuals constitutively express high levels of Fas,26 and are sensitive to Fas engagement27 (and our unpublished observations, August 1995), which may reflect their chronically activated state.37 Since these cells undergo spontaneous death in culture, an event that was not significantly increased in our hands by further activation via the TCR,35 we attempted what contribution, if any, Fas and FasL might make to the ex vivo death of PBL from HIV-infected individuals. Use was made of chimeric molecules composed of the extracellular portion of Fas fused to the Fc portion of human IgG (Fas:Fc), which binds to FasL and prevents activation-induced death of activated human PBL4 and murine T-cell hybridomas.6-8 PBL from HIV+ individuals were cultured for 3 days in the presence or absence of Fas:Fc (Fig 3). As previously observed,35 5% to 10% of PBL from uninfected individuals die under these culture conditions, while approximately 25% of cells from HIV+ patients with absolute CD4+ cell counts of 200 to 500 cells/μL die over the same time course. Strikingly, culture in the presence of Fas:Fc prevented the death of PBL from HIV+ blood, bringing the level of spontaneous death to less than 10%. This effect was specific for FasL in that a TNFR:Fc fusion protein, a potent antagonist of the cytotoxic effects of TNF and LT-α,28 had no effect on cell death under this condition.

Fig. 3.

Soluble Fas chimeric molecules block death of PBL from HIV-infected individuals. PBL from uninfected (n = 5) or HIV+ (n = 9) individuals were cultured for 3 days in complete medium at a concentration of 106 cells/mL in duplicate cultures. Cultures were performed in medium alone or in the presence of Fas:Fc or TNFR:Fc (10 μg/mL final concentration) and cell viability assessed.

Fig. 3.

Soluble Fas chimeric molecules block death of PBL from HIV-infected individuals. PBL from uninfected (n = 5) or HIV+ (n = 9) individuals were cultured for 3 days in complete medium at a concentration of 106 cells/mL in duplicate cultures. Cultures were performed in medium alone or in the presence of Fas:Fc or TNFR:Fc (10 μg/mL final concentration) and cell viability assessed.

Close modal

Expression of FasL by uninfected and HIV+ PBL.The requirement for Fas engagement in HIV-associated apoptosis raised the possibility that FasL is upregulated in cultured PBL from HIV+ blood. To examine this, a quantitative competitive reverse transcriptase (RT)-PCR assay was adapted to detect FasL mRNA in the limited number of cells that can be obtained from HIV+ individuals.31 38 For this assay, an internal deletion mutation of FasL cDNA was made, resulting in a sequence that competes with wild type FasL cDNA for the same pair of primers on an equimolar basis during PCR. When the mutant cDNA was amplified together with fresh or cultured PBL cDNA from HIV+ blood, agarose gel electrophoresis showed two bands (an example is shown in Fig 4) that correspond to the wild type (upper) and mutated (lower) cDNA, respectively. The ratio of the two bands changed in each sample as a constant amount of PBL cDNA was amplified in the presence of increasing amounts of competitor cDNA. Using laser densitometry, it was possible to determine the amount of FasL cDNA obtained from these cells. The analysis of PBL from multiple donors is summarized in Fig 5A. Interestingly, the levels of FasL mRNA present in fresh PBL from HIV and HIV+ blood was similar, and culturing the cells in complete medium overnight resulted in a threefold to fivefold increase in FasL mRNA, both in PBL from uninfected and PBL from HIV-infected donors.

Fig. 4.

Competitive PCR for FasL mRNA in fresh and cultured PBL. mRNA in nonnuclear lysates of fresh or cultured (20 hours) PBL from an HIV-infected donor was reverse-transcribed using random primers and amplified by PCR in the presence of increasing amounts of mutated cDNA (lane 1 through lane 6, the amounts of mutated cDNA are 10−3, 2 × 10−3, 4 × 10−3, 10−2, 2 × 10−2, and 4 × 10−2 amol, respectively). The PCR products were analyzed by agarose gel electrophoresis. The wild type cDNA is seen as a 241-bp band, while the mutated cDNA migrates as a 214-bp band.

Fig. 4.

Competitive PCR for FasL mRNA in fresh and cultured PBL. mRNA in nonnuclear lysates of fresh or cultured (20 hours) PBL from an HIV-infected donor was reverse-transcribed using random primers and amplified by PCR in the presence of increasing amounts of mutated cDNA (lane 1 through lane 6, the amounts of mutated cDNA are 10−3, 2 × 10−3, 4 × 10−3, 10−2, 2 × 10−2, and 4 × 10−2 amol, respectively). The PCR products were analyzed by agarose gel electrophoresis. The wild type cDNA is seen as a 241-bp band, while the mutated cDNA migrates as a 214-bp band.

Close modal
Fig. 5.

E64d does not inhibit apoptosis induced directly via Fas. Fresh PBL from uninfected (n = 3) or HIV+ (n = 4) individuals were treated with anti-Fas antibody CH11 (100 ng/mL) in the presence or absence of 50 μmol/L E64d. Cell viability was determined in duplicate wells by trypan blue exclusion after 20 hours of culture. (B) The PBL used in (A) were cultured in complete medium for 3 days in the presence or absence of 50 μmol/L E64d. Cell viability was determined in duplicate wells by trypan blue exclusion.

Fig. 5.

E64d does not inhibit apoptosis induced directly via Fas. Fresh PBL from uninfected (n = 3) or HIV+ (n = 4) individuals were treated with anti-Fas antibody CH11 (100 ng/mL) in the presence or absence of 50 μmol/L E64d. Cell viability was determined in duplicate wells by trypan blue exclusion after 20 hours of culture. (B) The PBL used in (A) were cultured in complete medium for 3 days in the presence or absence of 50 μmol/L E64d. Cell viability was determined in duplicate wells by trypan blue exclusion.

Close modal

E64d prevents upregulation of FasL in normal and HIV+ PBL.E64d could exert its effects on Fas-mediated killing by inhibiting signaling via Fas or, as in T-cell hybridomas, by preventing the upregulation of FasL. In agreement with studies done with normal T-cell blasts,36 we found that E64d prevented the ex vivo death of cultured PBL from HIV-infected blood (Fig 5B), but did not inhibit apoptosis of the same cells caused by cross-linking Fas with an activating anti-Fas antibody (Fig 5A). To determine if the effect of E64d on apoptosis of PBL from HIV+ blood is due to an effect on FasL expression, E64d was added to cultured PBL from HIV+ and HIV blood (Fig 6A). The induction of FasL mRNA in PBL from both uninfected and HIV-infected individuals during overnight culture was inhibited by E64d, which on average caused a greater than 75% decrease. In contrast, the levels of β-actin mRNA, measured by the same quantitative PCR technique, did not change significantly during these cultures (Fig 6B). Consistent with its effect on activation-induced apoptosis in T-cell hybridoma, these data demonstrate that E64d has no demonstrable effect on Fas-mediated signaling, but exerts its protective effect by prevention of FasL upregulation.

Fig. 6.

Culture of PBL results in upregulation of FasL mRNA, which is inhibited by E64d. (A) Mean FasL mRNA levels ± standard error of mean (SEM) in fresh PBL and PBL cultured for 20 hours in the absence or presence of E64d from uninfected (n = 6) and HIV-infected (n = 9) individuals. (B) Competitive PCR analysis of actin cDNA from HIV+ PBL (n = 4). Data are expressed as the arithmetic mean ± SEM.

Fig. 6.

Culture of PBL results in upregulation of FasL mRNA, which is inhibited by E64d. (A) Mean FasL mRNA levels ± standard error of mean (SEM) in fresh PBL and PBL cultured for 20 hours in the absence or presence of E64d from uninfected (n = 6) and HIV-infected (n = 9) individuals. (B) Competitive PCR analysis of actin cDNA from HIV+ PBL (n = 4). Data are expressed as the arithmetic mean ± SEM.

Close modal

Several lines of evidence suggest that proteases play an important role in apoptosis. One of the early indications came from studies on proteases in the granules of cytotoxic T cells (granzymes). These cysteine proteases are required for killer cells to rapidly induce apoptotic death of target cells.39,40 Genetic studies in C elegans have found that the ced-3 gene is required for developmental programmed cell death.41 Interestingly, ced-3 shares some homology with IL-1β converting enzyme (ICE),42 a cysteine protease that processes pro–IL-1 into its active form. Although ICE itself appears not involved in cell death process,43 a number of ICE homologs have been identified, and their role in the induction of apoptosis is an area of intense investigation.44 Inhibitors of ICE-like proteases have been found to block Fas- and TNF-mediated apoptosis, as well as apoptosis induced by a number of drugs, indicating activation of this protease superfamily is required for multiple forms of cell death.45-47 In contrast to ICE family protease inhibitors, E64d and other cysteine, as well as some serine, protease inhibitors selectively prevent activation-induced T-cell apoptosis; they do not inhibit T-cell death caused by anti-Fas, γ-irradiation, etoposide, or extracellular adenosine triphosphate (ATP).24,36,48 One protease that is of particular interest is calpain, a Ca2+-dependent cysteine protease that is specifically inhibited by E64d.49 Calpain is an ubiquitously expressed neutral protease whose substrates include spectrin, the epidermal growth factor (EGF ) receptor, Src, calcineurin, c-Jun, and c-Fos.50 While expressed at a low level in resting T cells, calpain is highly expressed upon activation.51 Since increases in intracellular Ca2+ can activate calpain, it is likely that calpain activity is enhanced in activated T cells. Although E64d is a calpain inhibitor that prevents FasL upregulation, the question of whether this protease is the relevant target is unknown.

Activation of T-cell hybridomas and mature T cells causes apoptosis by upregulating FasL and, in some cases, Fas. The results in this report demonstrate that E64d prevents this form of apoptosis not by interfering with Fas signaling, but by inhibiting the upregulation of FasL mRNA and protein. Given the previously reported antiapoptotic effect of E64d on PBL from HIV+ blood, we investigated the role of Fas and FasL in this form of cell death. The increased sensitivity of lymphocytes to Fas engagement could result from direct HIV infection, the effects of soluble products of HIV infection, or their state of activation. However, the majority of cell death in patients in the later stages of the disease appears to be an indirect effect of HIV, since the number of dying cells far exceeds the number that is detectable infected, and in lymph nodes it is predominantly uninfected bystander cells that undergo apoptosis.21,22 One candidate for the cause of the enhanced sensitivity of bystander PBL to apoptosis is HIV-1 Tat, which is present in the serum of HIV-infected individuals. In vitro, Tat has been shown to cause the apoptotic death of PBL from uninfected individuals.52,53 Furthermore, Tat upregulates expression of FasL and sensitizes uninfected T cells to killing by TCR-induced apoptosis.54 Interestingly, cross-linking CD4-bound gp120 with anti-gp120 antibodies enhances susceptibility of CD4+ T cells to TCR-mediated apoptosis,55 an effect that is enhanced by Tat and blocked by noncytotoxic anti-Fas F(ab′ )2 or soluble Fas:Fc fusion molecules.54 However, we found no evidence that FasL levels are abnormally elevated in either fresh or cultured PBL from HIV+ individuals compared with PBL from uninfected controls. Therefore, if Tat is playing a role in ex vivo PBL apoptosis, it is likely to be at the level of the response to Fas ligation, not FasL upregulation. HIV infection of severe combined immunodeficiency (SCID)-hu mice has also been shown to cause the death of thymocytes, particularly CD4+ CD8 cells.56,57 In addition, while anti-Fas killed both CD4+ and CD8+ T cells from HIV-infected individuals, CD4+ memory T cells were found to be more sensitive.27 These observations may account, at least in part, for the relatively selective loss of CD4+ T cells observed in vivo.

Interestingly, the levels of FasL mRNA expressed by fresh PBL from HIV+ and HIV individuals were comparable, as were the levels after upregulation in culture. Thus, in culture the effector molecule (FasL) was induced, but its receptor (Fas) was functionally present only on PBL from HIV+ blood. The ability of a soluble form of Fas to prevent cell death provides direct evidence that the interaction between these two molecules mediates HIV-associated T-cell apoptosis, demonstrating that PBL from individuals infected with HIV are abnormally sensitive to Fas-mediated killing by endogenously expressed FasL. Since FasL is normally upregulated by T-cell activation, this provides support for the hypothesis that periodic antigen-specific stimulation of peripheral CD4+ T cells may result in immune dysfunction and gradual cell loss.23,58 It is also noteworthy that while inhibitors of both cysteine and ICE family proteases can prevent Fas/FasL-dependent apoptosis, they appear to have different mechanisms of action; ICE family inhibitors prevent Fas-mediated killing,45,46 59 while the cysteine protease inhibitor E64d had no effect on Fas-mediated killing, but prevented upregulation of FasL. The finding that inhibition of FasL upregulation prevents HIV-associated PBL apoptosis may make it possible to determine to what extent inappropriate apoptosis contributes to the immunodeficiency of AIDS.

We are grateful to Dr H. Mitsuya and Dr L. J. Striker for their help and support; Dr R. Yarchoan, F. Merced-Galindez, and K. Wyvill for providing blood from HIV+ individuals; the NIH blood bank for providing uninfected blood; J. Jensen for making oligonucleotides; and Dr A. Weissman for critical review of the manuscript.

Supported in part by Grant No. IM663 from the American Cancer Society (Philadelphia, PA) and Grant No. AI33068 from the National Institutes of Health, Bethesda, MD, to C.F.W.

Address reprint requests to Jonathan Ashwell, MD, Rm 1B-40, Bldg 10, NIH, Bethesda, MD 20892-1152.

1
Cohen
JJ
Duke
RC
Fadok
VA
Sellins
KS
Apoptosis and programmed cell death in immunity.
Annu Rev Immunol
10
1992
267
2
Kappler
JW
Roehm
N
Marrack
P
T cell tolerance by clonal elimination in the thymus.
Cell
49
1987
273
3
Green
DR
Scott
DW
Activation-induced apoptosis in lymphocytes.
Curr Opin Immunol
6
1994
476
4
Alderson
MR
Tough
TW
Davis-Smith
T
Braddy
S
Falk
B
Schooley
KA
Goodwin
RG
Smith
CA
Ramsdell
F
Lynch
DH
Fas ligand mediates activation-induced cell death in human T lymphocytes.
J Exp Med
181
1995
71
5
Dhein
J
Walczak
H
Bäumler
C
Debatin
K-M
Krammer
PH
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95).
Nature
373
1995
438
6
Brunner
T
Modil
RJ
LaFace
D
Yoo
NJ
Mahboubi
A
Echeverri
F
Martin
SJ
Force
WR
Lynch
DH
Ware
CF
Green
DR
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.
Nature
373
1995
441
7
Ju
S-T
Panka
DJ
Cui
H
Ettinger
R
El-Khatib
M
Sherr
DH
Stanger
BZ
Marchak-Rothstein
A
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.
Nature
373
1995
444
8
Yang
Y
Mercep
M
Ware
CF
Ashwell
JD
Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
J Exp Med
181
1995
1673
9
Watanabe-Fukunaga
R
Brannan
CI
Copeland
NG
Jenkins
NA
Nagata
S
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
Nature
356
1992
314
10
Russell
JH
Rush
B
Weaver
C
Wang
R
Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide.
Proc Natl Acad Sci USA
90
1993
4409
11
Takahashi
T
Tanaka
M
Brannan
CI
Jenkins
NA
Copeland
NG
Suda
T
Nagata
S
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Cell
76
1994
969
12
Rieux-Laucat
F
Le Deist
F
Hivroz
C
Roberts
IAG
Debatin
KM
Fischer
A
de Villartay
JP
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
Science
268
1995
1347
13
Fisher
GH
Rosenberg
FJ
Straus
SE
Dale
JK
Middelton
LA
Lin
AY
Strober
W
Lenardo
MJ
Puck
JM
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
Cell
81
1995
935
14
Fauci
AS
The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis.
Science
239
1988
617
15
Schnittman
SM
Fauci
AS
Human immunodeficiency virus and acquired immunodeficiency syndrome: An update.
Adv Intern Med
39
1994
305
16
Groux
H
Torpier
G
Monté
D
Mouton
Y
Capron
A
Ameisen
JC
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.
J Exp Med
175
1992
331
17
Meyaard
L
Otto
SA
Jonker
RR
Mijinster
MJ
Keet
RPM
Miedema
F
Programmed death of T cells in HIV-1 infection.
Science
257
1992
217
18
Geougeon
M-L
Montagnier
L
Apoptosis in AIDS.
Science
260
1993
1269
19
Gougeon
M-L
Garcia
S
Heeney
J
Tschopp
R
Lecoeur
H
Guetard
D
Rame
V
Dauguet
C
Montagnier
L
Programmed cell death in AIDS-related HIV and SIV infection.
AIDS Res Hum Retroviruses
9
1993
553
20
Estaquier
J
Idziorek
T
De Bels
F
Barré-Sinoussi
F
Hurtrel
B
Aubertin
A-M
Venet
A
Mehtali
M
Muchmore
E
Michel
P
Mouton
Y
Girard
M
Ameisen
JC
Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
Proc Natl Acad Sci USA
91
1994
9431
21
Finkel
TH
Tudor-Williams
G
Banda
NK
Cotton
MF
Curiel
T
Monks
C
Baba
TW
Ruprecht
RM
Kupfer
A
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.
Nat Med
1
1995
129
22
Muro-Cacho
CA
Pantaleo
G
Fauci
AS
Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.
J Immunol
154
1995
5555
23
Ameisen
JC
Programmed cell death and AIDS: From hypothesis to experiment.
Immunol Today
13
1992
388
24
Sarin
A
Adams
DH
Henkart
PA
Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells.
J Exp Med
178
1993
1693
25
Sarin
A
Clerici
M
Blatt
SP
Hendrix
CW
Shearer
GM
Henkart
PA
Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors.
J Immunol
153
1994
862
26
Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH: High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101, 1994 (letter)
27
Katsikis
PD
Wunderlich
ES
Smith
CA
Herzenberg
LA
Herzenberg
LA
Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
J Exp Med
181
1995
2029
28
Crowe
PD
VanArsdale
TL
Walter
BN
Dahms
KM
Ware
CF
Production of lymphotoxin (LTα) and a soluble dimeric form of its receptor using the baculovirus expression system.
J Immunol Methods
168
1994
79
29
Ashwell
JD
Cunningham
RE
Noguchi
PD
Hernandez
D
Cell growth cycle block of T cell hybridomas upon activation with antigen.
J Exp Med
165
1987
173
30
Rouvier
E
Luciani
M-F
Golstein
P
Fas involvement in Ca2+-independent T cell-mediated cytotoxicity.
J Exp Med
177
1993
195
31
Yang
C-W
Vlassara
H
Peten
EP
He
C-J
Striker
GE
Striker
LJ
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Proc Natl Acad Sci USA
91
1994
9436
32
Yang
Y
Vacchio
MS
Ashwell
JD
9-Cis retinoic acid inhibits activation-driven T cell apoptosis: Implications for retinoid X receptor involvement in thymocyte development.
Proc Natl Acad Sci USA
90
1993
6170
33
Mercep
M
Bluestone
JA
Noguchi
PD
Ashwell
JD
Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
J Immunol
140
1988
324
34
Chomczynski
P
Sacchi
N
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162
1987
156
35
Yang
Y
Bailey
J
Vacchio
MS
Yarchoan
R
Ashwell
JD
Retinoic acid inhibition of ex vivo HIV-associated apoptosis of peripheral blood cells.
Proc Natl Acad Sci USA
92
1995
3051
36
Sarin
A
Nakajima
H
Henkart
PA
A protease-dependent TCR-induced death pathway in mature lymphocytes.
J Immunol
154
1995
5806
37
Fauci
AS
Multifactorial nature of human immunodeficiency virus disease: Implications for therapy.
Science
262
1993
1011
38
Peten EP, Garcia-Perez A, Terada Y, Woodrow D, Martin BM, Striker GE, Striker LJ: Age-related changes in α1 and α2-chain type IV collagen mRNAs in adult mouse glomeruli: Competitive PCR. Am J Physiol 263:F951, 1992
39
Henkart
PA
Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules.
Immunity
1
1994
343
40
Heusel
JW
Wesselschmidt
RL
Shresta
S
Russell
JH
Ley
TJ
Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.
Cell
76
1994
977
41
Ellis
HM
Horvitz
HR
Genetic control of programmed cell death in the nematode C. elegans.
Cell
44
1986
817
42
Yuan
J
Shaham
S
Ledoux
S
Ellis
HM
Horvitz
HR
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzyme.
Cell
75
1993
641
43
Li
P
Allen
H
Banerjee
S
Franklin
S
Herzog
L
Johnston
C
McDowell
J
Paskind
M
Roadman
L
Salfeld
J
Towne
E
Tracey
D
Wardwell
S
Wei
F-Y
Wong
W
Kamon
R
Seshadri
T
Mice-deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock.
Cell
80
1995
401
44
Martin
SJ
Green
DR
Protease activation during apoptosis: Death by a thousand cuts?
Cell
82
1995
349
45
Enari
M
Hug
H
Nagata
S
Involvement of an ICE-like protease in Fas-mediated apoptosis.
Nature
375
1995
78
46
Los
M
Van de Craen
M
Penning
LC
Schenk
H
Westendorp
M
Baeuerle
PA
Dröge
W
Krammer
PH
Fiers
W
Schulze-Osthoff
K
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.
Nature
375
1995
81
47
Zhu
H
Fearnhead
HO
Cohen
GM
An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells.
FEBS Lett
374
1995
303
48
Wright
SC
Wei
QS
Zhong
J
Zheng
H
Kinder
DH
Larrick
JW
Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation.
J Exp Med
180
1994
2113
49
McGowan
EB
Becker
E
Detwiler
TC
Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d.
Biochem Biophys Res Commun
158
1989
432
50
Saido
TC
Sorimachi
H
Suzuki
K
Calpain: New perspectives in molecular diversity and physiological-pathological involvement.
FASEB J
8
1994
814
51
Deshpande
RV
Goust
J-M
Chakraboarti
AK
Barbosa
E
Hogan
EL
Banik
NL
Calpain expression in lymphoid cells: Increased mRNA and protein levels after cell activation.
J Biol Chem
270
1995
2497
52
Li
CJ
Friedman
DJ
Wang
C
Metelev
V
Pardee
AB
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.
Science
268
1995
429
53
Purvis
SF
Jacobberger
JW
Sramkoski
RM
Patki
AG
Lederman
MM
HIV type 1 Tat protein induces apoptosis and death in Jurkat cells.
AIDS Res Hum Retroviruses
11
1995
443
54
Westendorp
MO
Frank
R
Ochsenbauer
C
Stricker
K
Dhein
J
Walczak
H
Debatin
K-M
Krammer
PH
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Nature
375
1995
497
55
Banda
NK
Bernier
J
Kurahara
DK
Kurrle
R
Haigwood
N
Sekaly
R-P
Finkel
TH
Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.
J Exp Med
176
1992
1099
56
Aldrovandi
G
Feuer
G
Gao
L
Jamieson
B
Kristeva
M
Chen
ISY
Zack
JA
The SCID-hu mouse as a model for HIV-1 infection.
Nature
363
1993
732
57
Bonyhadi
ML
Rabin
L
Salimi
S
Brown
DA
Kosek
J
McCune
JM
Kaneshima
H
HIV induces thymus depletion in vivo.
Nature
363
1993
728
58
Ameisen
JC
Capron
A
Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis.
Immunol Today
12
1991
102
59
Tewari
M
Dixit
VM
Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product.
J Biol Chem
270
1995
3255
Sign in via your Institution